Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

On July 8, 2025, the world watched as King Charles III welcomed French President Emmanuel Macron and his wife, Brigitte, to ...

In other instances, the condition can impact quality of life. But in extreme cases, sarcoidosis can be life-threatening. So, ...

Good side dishes are always welcomed at a Fourth of July feast in Detroit. And there are times when the dish preparers are ...

Infliximab is the first new drug for patients with pulmonary sarcoidosis for 50 years.

It affects about 1 in 10,000 people in the UK, according the charity Sarcoidosis UK. As well as the lungs it can also affect the skin, eyes, joints, nervous system, heart and other parts of the body.

In December the right eye became red and painful. She consulted an ophthalmologist, who made a diagnosis of possible sarcoidosis and for 6 weeks treated her with streptomycin.

Sarcoidosis is the great imitator and may resemble many other types of lesions including annular, psoriasiform, ichthyosiform, ulcerative, hypopigmented, subcutaneous, and erythrodermic lesions. 2,7 ...

Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin disease.

ORLANDO, Fla. — Despite a constellation of available data points regarding prognosis and impacted organs, researchers have so far been unable to connect the dots and form a better ...